188 related articles for article (PubMed ID: 25826114)
21. The nature and time course of cognitive side effects during electroconvulsive therapy in the elderly.
Rubin EH; Kinscherf DA; Figiel GS; Zorumski CF
J Geriatr Psychiatry Neurol; 1993; 6(2):78-83. PubMed ID: 8512634
[TBL] [Abstract][Full Text] [Related]
22. The APOE ɛ4 allele modulates brain white matter integrity in healthy adults.
Heise V; Filippini N; Ebmeier KP; Mackay CE
Mol Psychiatry; 2011 Sep; 16(9):908-16. PubMed ID: 20820167
[TBL] [Abstract][Full Text] [Related]
23. The effects of ECT on cognitive functioning in the elderly: a review.
Tielkes CE; Comijs HC; Verwijk E; Stek ML
Int J Geriatr Psychiatry; 2008 Aug; 23(8):789-95. PubMed ID: 18311845
[TBL] [Abstract][Full Text] [Related]
24. Transient increase of plasma concentrations of amyloid β peptides after electroconvulsive therapy.
Zimmermann R; Schmitt H; Rotter A; Sperling W; Kornhuber J; Lewczuk P
Brain Stimul; 2012 Jan; 5(1):25-9. PubMed ID: 22037136
[TBL] [Abstract][Full Text] [Related]
25. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
[TBL] [Abstract][Full Text] [Related]
26. A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden.
Skoog I; Waern M; Duberstein P; Blennow K; Zetterberg H; Börjesson-Hanson A; Östling S; Guo X; Kern J; Gustafson D; Gudmundsson P; Marlow T; Kern S
Biol Psychiatry; 2015 Nov; 78(10):730-6. PubMed ID: 25708227
[TBL] [Abstract][Full Text] [Related]
27. White matter lesion load increases the risk of low CSF Aβ42 in apolipoprotein E-ɛ4 carriers attending a memory clinic.
Stenset V; Hofoss D; Johnsen L; Berstad AE; Negaard A; Skinningsrud A; Gjerstad L; Fladby T
J Neuroimaging; 2011 Apr; 21(2):e78-82. PubMed ID: 19888930
[TBL] [Abstract][Full Text] [Related]
28. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
31. Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects.
Perera TD; Luber B; Nobler MS; Prudic J; Anderson C; Sackeim HA
Neuropsychopharmacology; 2004 Apr; 29(4):813-25. PubMed ID: 14735129
[TBL] [Abstract][Full Text] [Related]
32. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
[TBL] [Abstract][Full Text] [Related]
33. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury.
Alexander S; Kerr ME; Kim Y; Kamboh MI; Beers SR; Conley YP
J Neurotrauma; 2007 May; 24(5):790-7. PubMed ID: 17518534
[TBL] [Abstract][Full Text] [Related]
35. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
36. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
37. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal DNA damage in APOE ɛ4 carriers and noncarriers does not appear to be different.
Chua A; Thomas P; Clifton P; Fenech M
Environ Mol Mutagen; 2015 Oct; 56(8):694-708. PubMed ID: 25820038
[TBL] [Abstract][Full Text] [Related]
39. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
Ellis KA; Lim YY; Harrington K; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P;
J Alzheimers Dis; 2013; 34(4):861-71. PubMed ID: 23302660
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E ɛ4, Cognitive Function, and Pain Experience in Down Syndrome: A Pilot Study.
de Knegt NC; Schuengel C; Evenhuis HM; Lobbezoo F; Scherder EJ
Arch Clin Neuropsychol; 2016 Aug; 31(5):389-400. PubMed ID: 27193365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
